0001127602-15-006771.txt : 20150219
0001127602-15-006771.hdr.sgml : 20150219
20150218164102
ACCESSION NUMBER: 0001127602-15-006771
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150217
FILED AS OF DATE: 20150218
DATE AS OF CHANGE: 20150218
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOGEN IDEC INC.
CENTRAL INDEX KEY: 0000875045
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330112644
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 7814642000
MAIL ADDRESS:
STREET 1: 225 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: BIOGEN IDEC INC
DATE OF NAME CHANGE: 20031112
FORMER COMPANY:
FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE
DATE OF NAME CHANGE: 19970530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Holtzman Steven H
CENTRAL INDEX KEY: 0001300247
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19311
FILM NUMBER: 15628560
MAIL ADDRESS:
STREET 1: 115 POWERS ROAD
CITY: SUDBURY
STATE: MA
ZIP: 01776
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-02-17
0000875045
BIOGEN IDEC INC.
BIIB
0001300247
Holtzman Steven H
BIOGEN IDEC INC.
225 BINNEY STREET
CAMBRIDGE
MA
02142
1
EVP Corporate Development
Common Stock
2015-02-17
4
S
0
2128
389.11
D
4321
D
Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
Matthew S. Gilman, Attorney-in-Fact for Steven H. Holtzman
2015-02-18